Diagnostics/Test portfolio/Eye Disease Prevention

PREVENTION · PRV06

Eye Disease Prevention

Focused analysis of genes associated with selected inherited retinal disorders and glaucoma where early ophthalmic surveillance may matter.

STARTING MATERIAL

1–2 ml EDTA blood or 1–2 µg genomic DNA. Alternative material must be confirmed before collection or shipment.

METHOD / ANALYTICAL SCOPE

Targeted next-generation sequencing of the complete coding sequence and relevant splice regions of the selected genes; this is not a hotspot-only screen.

MEDICAL REPORT

Clinically classified findings, an explanation of the inherited risk, and recommendations for medical follow-up or preventive discussion.

TURNAROUND

Confirmed after case and sample review.

CLINICAL VALUE

Where this test is strongest

Focused 5-gene scope

Retinal-disease and glaucoma genes

Can support earlier specialist surveillance

Full-gene analysis

LIMITATIONS

What must remain visible

!A predisposition is not a diagnosis and does not predict if or when disease will occur.

!A negative result does not remove all inherited or non-genetic risk; selection and interpretation require medical context.

!This is a focused preventive module, not a comprehensive inherited-eye-disease diagnostic panel.

GENE & ANALYTICAL SCOPE

5 published genes

Focused five-gene preventive eye-disease scope.

Eye diseasesPRV06 · 5 published genes
+

Complete panel scope (5 genes).

ABCA4CRB1GUCY2DMYOCRPE65
Search another gene across the portfolio

BEFORE ORDERING

Confirm the current laboratory specification.

The official case review and quotation confirm eligibility, accepted material, validated coverage and variant classes, consent, turnaround, price, and report pathway.

Prepare case enquiry
WhatsApp